# Portillo's Inc.: financial statements, quarterly

PTLO · Nasdaq · CIK 1871509 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/ptlo.md) · [Financials](/companies/ptlo/financials.md) · [Filings](/companies/ptlo/filings.md) · [Insiders](/companies/ptlo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ptlo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [167](/filings/0001871509-24-000139.md) | [188 d](/filings/0001871509-26-000012.md) | [166](/filings/0001871509-25-000094.md) | [182](/filings/0001871509-25-000122.md) | [178](/filings/0001871509-25-000152.md) | [185 d](/filings/0001871509-26-000012.md) | [176](/filings/0001871509-26-000033.md) | [188](/filings/0001871509-26-000056.md) | [181](/filings/0001871509-25-000152.md) | [186 d](/filings/0001871509-26-000012.md) | [183](/filings/0001871509-26-000033.md) | [199](/filings/0001871509-26-000056.md) |
| Operating income | $m | [15.1](/filings/0001871509-24-000139.md) | [14.5 d](/filings/0001871509-26-000012.md) | [10.1](/filings/0001871509-25-000094.md) | [18.1](/filings/0001871509-25-000122.md) | [16.0](/filings/0001871509-25-000152.md) | [13.8 d](/filings/0001871509-26-000012.md) | [10.4](/filings/0001871509-26-000033.md) | [17.5](/filings/0001871509-26-000056.md) | [5.4](/filings/0001871509-25-000152.md) | [10.3 d](/filings/0001871509-26-000012.md) | [4.5](/filings/0001871509-26-000033.md) | [13.8](/filings/0001871509-26-000056.md) |
| Income tax | $m | [2.6](/filings/0001871509-24-000139.md) | [(0.4) d](/filings/0001871509-26-000012.md) | [(1.1)](/filings/0001871509-25-000094.md) | [3.5](/filings/0001871509-25-000122.md) | [2.5](/filings/0001871509-25-000152.md) | [1.9 d](/filings/0001871509-26-000012.md) | [1.4](/filings/0001871509-26-000033.md) | [3.7](/filings/0001871509-26-000056.md) | [(1.2)](/filings/0001871509-25-000152.md) | [(0.8) d](/filings/0001871509-26-000012.md) | [(0.2)](/filings/0001871509-26-000033.md) | [1.8](/filings/0001871509-26-000056.md) |
| Net income | $m | [4.4](/filings/0001871509-24-000139.md) | [7.8 d](/filings/0001871509-26-000012.md) | [4.6](/filings/0001871509-25-000094.md) | [6.5](/filings/0001871509-25-000122.md) | [7.2](/filings/0001871509-25-000152.md) | [11.3 d](/filings/0001871509-26-000012.md) | [3.3](/filings/0001871509-26-000033.md) | [8.7](/filings/0001871509-26-000056.md) | [1.2](/filings/0001871509-25-000152.md) | [6.1 d](/filings/0001871509-26-000012.md) | [(0.4)](/filings/0001871509-26-000033.md) | [6.9](/filings/0001871509-26-000056.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001871509-24-000139.md) | not reported | [0.08](/filings/0001871509-25-000094.md) | [0.10](/filings/0001871509-25-000122.md) | [0.11](/filings/0001871509-25-000152.md) | not reported | [0.05](/filings/0001871509-26-000033.md) | [0.12](/filings/0001871509-26-000056.md) | [0.02](/filings/0001871509-25-000152.md) | not reported | [(0.01)](/filings/0001871509-26-000033.md) | [0.09](/filings/0001871509-26-000056.md) |
| Basic EPS | $ per share | [0.08](/filings/0001871509-24-000139.md) | not reported | [0.08](/filings/0001871509-25-000094.md) | [0.10](/filings/0001871509-25-000122.md) | [0.12](/filings/0001871509-25-000152.md) | not reported | [0.05](/filings/0001871509-26-000033.md) | [0.13](/filings/0001871509-26-000056.md) | [0.02](/filings/0001871509-25-000152.md) | not reported | [(0.01)](/filings/0001871509-26-000033.md) | [0.10](/filings/0001871509-26-000056.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-24) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [39.1](/filings/0001871509-23-000139.md) | [41.9](/filings/0001871509-25-000016.md) | [42.4](/filings/0001871509-24-000076.md) | [41.9](/filings/0001871509-24-000103.md) | [46.9](/filings/0001871509-24-000139.md) | [52.7](/filings/0001871509-26-000012.md) | [41.9](/filings/0001871509-25-000094.md) | [50.3](/filings/0001871509-25-000122.md) | [50.1](/filings/0001871509-25-000152.md) | [51.5](/filings/0001871509-26-000056.md) | [51.9](/filings/0001871509-26-000033.md) | [49.8](/filings/0001871509-26-000056.md) |
| Total assets | $m | [1,358](/filings/0001871509-23-000139.md) | [1,386](/filings/0001871509-25-000016.md) | [1,417](/filings/0001871509-24-000076.md) | [1,439](/filings/0001871509-24-000103.md) | [1,471](/filings/0001871509-24-000139.md) | [1,500](/filings/0001871509-26-000012.md) | [1,499](/filings/0001871509-25-000094.md) | [1,554](/filings/0001871509-25-000122.md) | [1,591](/filings/0001871509-25-000152.md) | [1,607](/filings/0001871509-26-000056.md) | [1,618](/filings/0001871509-26-000033.md) | [1,625](/filings/0001871509-26-000056.md) |
| Current liabilities | $m | [90.0](/filings/0001871509-23-000139.md) | [105](/filings/0001871509-25-000016.md) | [117](/filings/0001871509-24-000076.md) | [109](/filings/0001871509-24-000103.md) | [124](/filings/0001871509-24-000139.md) | [136](/filings/0001871509-26-000012.md) | [166](/filings/0001871509-25-000094.md) | [171](/filings/0001871509-25-000122.md) | [187](/filings/0001871509-25-000152.md) | [194](/filings/0001871509-26-000056.md) | [200](/filings/0001871509-26-000033.md) | [189](/filings/0001871509-26-000056.md) |
| Total liabilities | $m | [910](/filings/0001871509-23-000139.md) | [925](/filings/0001871509-25-000016.md) | [965](/filings/0001871509-24-000076.md) | [975](/filings/0001871509-24-000103.md) | [994](/filings/0001871509-24-000139.md) | [1,010](/filings/0001871509-26-000012.md) | [1,004](/filings/0001871509-25-000094.md) | [1,066](/filings/0001871509-25-000122.md) | [1,102](/filings/0001871509-25-000152.md) | [1,109](/filings/0001871509-26-000056.md) | [1,118](/filings/0001871509-26-000033.md) | [1,115](/filings/0001871509-26-000056.md) |
| Long-term debt | $m | [287](/filings/0001871509-23-000139.md) | [284](/filings/0001871509-25-000016.md) | [282](/filings/0001871509-24-000076.md) | [279](/filings/0001871509-24-000103.md) | [279](/filings/0001871509-24-000139.md) | [275](/filings/0001871509-26-000012.md) | [242](/filings/0001871509-25-000094.md) | [241](/filings/0001871509-25-000122.md) | [239](/filings/0001871509-25-000152.md) | [238](/filings/0001871509-26-000056.md) | [237](/filings/0001871509-26-000033.md) | [235](/filings/0001871509-26-000056.md) |
| Current portion of debt | $m | [7.5](/filings/0001871509-23-000139.md) | [7.5](/filings/0001871509-25-000016.md) | [7.5](/filings/0001871509-24-000076.md) | [9.4](/filings/0001871509-24-000103.md) | [9.4](/filings/0001871509-24-000139.md) | [11.3](/filings/0001871509-26-000012.md) | [4.7](/filings/0001871509-25-000094.md) | [6.3](/filings/0001871509-25-000122.md) | [6.3](/filings/0001871509-25-000152.md) | [6.3](/filings/0001871509-26-000056.md) | [6.3](/filings/0001871509-26-000033.md) | [6.3](/filings/0001871509-26-000056.md) |
| Short-term borrowings | $m | not reported | [15.0](/filings/0001871509-25-000016.md) | [32.0](/filings/0001871509-24-000076.md) | [17.0](/filings/0001871509-24-000103.md) | [14.0](/filings/0001871509-24-000139.md) | [25.0](/filings/0001871509-26-000012.md) | [73.0](/filings/0001871509-25-000094.md) | [70.0](/filings/0001871509-25-000122.md) | [77.0](/filings/0001871509-25-000152.md) | [90.0](/filings/0001871509-26-000056.md) | [104](/filings/0001871509-26-000033.md) | [97.0](/filings/0001871509-26-000056.md) |
| Shareholders' equity | $m | [312](/filings/0001871509-23-000139.md) | [322](/filings/0001871509-25-000016.md) | [361](/filings/0001871509-24-000076.md) | [370](/filings/0001871509-24-000103.md) | [382](/filings/0001871509-24-000139.md) | [401](/filings/0001871509-26-000012.md) | [407](/filings/0001871509-25-000094.md) | [459](/filings/0001871509-25-000122.md) | [459](/filings/0001871509-25-000152.md) | [468](/filings/0001871509-26-000056.md) | [471](/filings/0001871509-26-000033.md) | [480](/filings/0001871509-26-000056.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.3 d](/filings/0001871509-24-000139.md) | [17.2 d](/filings/0001871509-26-000012.md) | [9.1](/filings/0001871509-25-000094.md) | [32.6 d](/filings/0001871509-25-000122.md) | [30.3 d](/filings/0001871509-25-000152.md) | [26.1 d](/filings/0001871509-26-000012.md) | [9.5](/filings/0001871509-26-000033.md) | [19.2 d](/filings/0001871509-26-000056.md) | [20.0 d](/filings/0001871509-25-000152.md) | [23.2 d](/filings/0001871509-26-000012.md) | [17.6](/filings/0001871509-26-000033.md) | [17.6 d](/filings/0001871509-26-000056.md) |
| Capital expenditure | $m | [20.3 d](/filings/0001871509-24-000139.md) | [30.3 d](/filings/0001871509-26-000012.md) | [16.9](/filings/0001871509-25-000094.md) | [17.0 d](/filings/0001871509-25-000122.md) | [22.6 d](/filings/0001871509-25-000152.md) | [31.7 d](/filings/0001871509-26-000012.md) | [19.0](/filings/0001871509-26-000033.md) | [14.0 d](/filings/0001871509-26-000056.md) | [25.0 d](/filings/0001871509-25-000152.md) | [32.3 d](/filings/0001871509-26-000012.md) | [18.5](/filings/0001871509-26-000033.md) | [11.7 d](/filings/0001871509-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [42.6](/filings/0001871509-23-000139.md) | [49.6](/filings/0001871509-24-000076.md) | [58.6](/filings/0001871509-24-000103.md) | [58.8](/filings/0001871509-24-000139.md) | [60.5](/filings/0001871509-25-000094.md) | [64.6](/filings/0001871509-25-000122.md) | [64.9](/filings/0001871509-25-000152.md) | [66.5](/filings/0001871509-26-000033.md) | [69.9](/filings/0001871509-26-000056.md) | [74.0](/filings/0001871509-25-000152.md) | [72.1](/filings/0001871509-26-000033.md) | [73.2](/filings/0001871509-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 61,794,622 at 2024-07-30, from the cover of the [10-Q filed 2024-08-06](/filings/0001871509-24-000103.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.